Your session is about to expire
← Back to Search
Herbal Supplement
Milk Thistle for Body Dysmorphic Disorder
Phase 2
Waitlist Available
Led By Jon E Grant, JD, MD, MPH
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 9 weeks
Summary
This trial is testing milk thistle, a plant known for its health benefits, to see if it can help adults with body dysmorphic disorder. The study involves 15 participants who will receive milk thistle over several weeks. Researchers hope that milk thistle's antioxidant and anti-inflammatory properties will improve symptoms of this condition. Milk thistle, derived from the species Silybum marianum, is traditionally used as a hepatoprotective agent.
Eligible Conditions
- Body Dysmorphic Disorder
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and 9 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 9 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Yale Brown Obsessive Compulsive Scale Modified for Body Dysmorphic Disorder (BDD-YBOCS)
Secondary study objectives
Clinical Global Impression- Severity and Improvement (CGI)
Hamilton Anxiety Rating Scale (HAM-A)
Hamilton Depression Rating Scale (HAM-D)
+1 moreSide effects data
From 2022 Phase 2 trial • 55 Patients • NCT0233763418%
Headache
6%
Reduced appetite
100%
80%
60%
40%
20%
0%
Study treatment Arm
Placebo
Milk Thistle
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Silymarin (Milk Thistle)Experimental Treatment1 Intervention
Each subject will have a 4 week treatment phase with milk thistle.
Group II: PlaceboPlacebo Group1 Intervention
4 week placebo phase before or after milk thistle phase depending on randomization.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Milk Thistle
2015
Completed Phase 2
~80
Find a Location
Who is running the clinical trial?
University of ChicagoLead Sponsor
1,054 Previous Clinical Trials
759,959 Total Patients Enrolled
Jon E Grant, JD, MD, MPHPrincipal InvestigatorUniversity of Chicago
7 Previous Clinical Trials
889 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger